Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-005053

Chief Executive Officer sold 11,096 shares at $3.19 ($35,416)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rawcliffe Adrian Chief Executive Officer 2022-01-18 Sale −11,096 $3.19 $35,416 12,312 D
Open-market sales · 11,096 sh · avg $3.19 · $35,416
Loading xslF345X03/tm221700-15_4seq.xml…